Surveillance in the digestive tract by capsule endoscopy after administration of immune checkpoint inhibitors
Not Applicable
- Conditions
- eoplasms (Malignant melanoma, Non-small cell lung cancer, and so on)
- Registration Number
- JPRN-UMIN000022149
- Lead Sponsor
- Keio University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
1. Pregnant female. 2. Patients with cardiac pacemakers or other medical electronic equipment. 3. Patients who have history of the ileus or stricture or fistula of the intestine. 4. Diagnosed or suspected Crohn's disease. 5. Patients with peritoneal dissemination. 6. Patients who are unsuccessful or difficult to perform esophagogastroduodenoscopy, colonoscopy, and small-bowel endoscopy. 7. Patients with dysphagia. 8. Allergy for mosapride, dimethicone, and low-volume polyethylene glycol solution (Moviprep). 9. Other conditions not suitable for this study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Endoscopic findings and Prevalence rate
- Secondary Outcome Measures
Name Time Method